NL-OMON32923
Recruiting
Not Applicable
Imaging of [11C]erlotinib pharmacokinetics in non small cell lung cancer patients; an in vivo study with positron emission tomography - Imaging of [11C]erlotinib kinetics in non small cell lung carcinoma
Overview
- Phase
- Not Applicable
- Status
- Recruiting
- Enrollment
- 10
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational invasive
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Patients age of 18\-70 years
- •Patients with non small cell lung cancer planned to receive erlotinib
- •Life expectancy of at least 12 weeks
- •Malignant lesion of at least 1\.5 cm diameter within the chest as measured by CT
- •Performance status Karnofsky index \>60%
- •Laboratory requirements
- •Written informed consent
Exclusion Criteria
- •Claustrophobia
- •Pregnant or lactating patients
- •Patients having metal implants (e.g. pacemakers)
- •Concurrent or previous treatment with experimental drugs
- •Haemoglobin level \< 6 mmol/l
Investigators
Similar Trials
Recruiting
Not Applicable
High-sensitivity imaging of erlotinib in resected non-small-cell lung cancerJPRN-UMIN000009745Department of Internal Medicine Division of Medical Oncology & Respiratory Medicine Shimane University Faculty of Medicine1
Completed
Not Applicable
[11C]Erlotinib pharmacokinetics: an in vivo study using positron emission tomography in non-small cell lung cancer patients with and without erlotinib therapy.lung cancernon-small cell lung carcinoma10038666NL-OMON36826Vrije Universiteit Medisch Centrum10
Not yet recruiting
Not Applicable
[11C]Erlotinib in non-small cell lung cancer patients with and without erlotinib therapy.on-small cell lung cancer NSCLCNiet-kleincellig longkankerNL-OMON28948VU University Medical Center10
Completed
Not Applicable
Efficacy and pharmacokinetics study of erlotinib in patients with non-small cell lung cancerAdvanced non-small cell lung cancerJPRN-UMIN000012862Shizuoka cancer center70
Not yet recruiting
Phase 2
The Utility of PET/CT in Erlotinib treatment for Non-Small Cell canceron-small cell lung cancerJPRN-UMIN000002044Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine20